Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
65.68
-1.02 (-1.53%)
Mar 31, 2025, 1:41 PM EDT - Market open

Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $2.09 billion. The enterprise value is $1.98 billion.

Market Cap 2.09B
Enterprise Value 1.98B

Important Dates

The last earnings date was Monday, March 17, 2025, before market open.

Earnings Date Mar 17, 2025
Ex-Dividend Date n/a

Share Statistics

Belite Bio has 31.84 million shares outstanding. The number of shares has increased by 14.83% in one year.

Current Share Class n/a
Shares Outstanding 31.84M
Shares Change (YoY) +14.83%
Shares Change (QoQ) +2.52%
Owned by Insiders (%) 2.22%
Owned by Institutions (%) 1.11%
Float 14.04M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 14.56
P/TBV Ratio 14.57
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 24.31, with a Debt / Equity ratio of 0.00.

Current Ratio 24.31
Quick Ratio 24.09
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,999.80

Financial Efficiency

Return on equity (ROE) is -30.60% and return on invested capital (ROIC) is -21.04%.

Return on Equity (ROE) -30.60%
Return on Assets (ROA) -20.26%
Return on Invested Capital (ROIC) -21.04%
Return on Capital Employed (ROCE) -27.38%
Revenue Per Employee n/a
Profits Per Employee -$1.45M
Employee Count 25
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Belite Bio has paid $6,000 in taxes.

Income Tax 6,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +71.36% in the last 52 weeks. The beta is -1.54, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y) -1.54
52-Week Price Change +71.36%
50-Day Moving Average 60.81
200-Day Moving Average 57.60
Relative Strength Index (RSI) 55.15
Average Volume (20 Days) 48,042

Short Selling Information

Short Interest 89,202
Short Previous Month 81,302
Short % of Shares Out 0.61%
Short % of Float n/a
Short Ratio (days to cover) 1.65

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -40.00M
Pretax Income -31.62M
Net Income -36.14M
EBITDA -39.83M
EBIT -40.00M
Earnings Per Share (EPS) -$1.18
Full Income Statement

Balance Sheet

The company has $145.15 million in cash and $537,000 in debt, giving a net cash position of $144.61 million or $4.54 per share.

Cash & Cash Equivalents 145.15M
Total Debt 537,000
Net Cash 144.61M
Net Cash Per Share $4.54
Equity (Book Value) 145.82M
Book Value Per Share 4.58
Working Capital 141.02M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.23 million and capital expenditures -$116,000, giving a free cash flow of -$29.35 million.

Operating Cash Flow -29.23M
Capital Expenditures -116,000
Free Cash Flow -29.35M
FCF Per Share -$0.92
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -14.83%
Shareholder Yield -14.83%
Earnings Yield -1.70%
FCF Yield -1.38%

Analyst Forecast

The average price target for Belite Bio is $96.67, which is 47.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target $96.67
Price Target Difference 47.18%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1